AntiInfectiveMeds
Since 2010
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 90 | £0.33 | - | £29.85 | |
| 120 | £0.27 | £7.73 | £32.08 | |
| 180 | £0.22 | £20.59 | £39.11 | |
| 360 | £0.17 | £59.78 | £59.63 |
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 60 | £0.53 | - | £31.93 | |
| 90 | £0.41 | £11.30 | £36.60 | |
| 120 | £0.35 | £22.22 | £41.63 | |
| 180 | £0.28 | £45.78 | £50.00 | |
| 270 | £0.24 | £79.97 | £63.71 | |
| 360 | £0.22 | £113.27 | £78.30 |
| Quantity | Price per tablet | You save | Total price | |
|---|---|---|---|---|
| 30 | £1.45 | - | £43.56 | |
| 60 | £1.03 | £25.56 | £61.56 | |
| 90 | £0.89 | £50.82 | £79.86 | |
| 120 | £0.80 | £77.93 | £96.30 | |
| 180 | £0.73 | £129.86 | £131.49 | |
| 360 | £0.66 | £285.13 | £237.57 |
Your order is carefully packed and is dispatched within 24 hours. Here is what a typical package looks like.
Sized like a regular personal letter (approximately 24x11x0.7 cm), with no indication of what is inside.
| Delivery Method | Estimated delivery |
|---|---|
| Express Free for orders over £222.24 | Estimated delivery to the UK: 4-7 days |
| Standard Free for orders over £148.16 | Estimated delivery to the UK: 14-21 days |
| Country | Brand Names |
|---|---|
| United Kingdom | Ciprofloxacin Accord Ciproxin |
We stock Cipro (ciprofloxacin) film-coated tablets in three strengths - 250 mg, 500 mg and 750 mg - with pack sizes running from 30 up to 360 tablets. This guide sets out exactly what we offer, how the pack sizes compare on value, and what to weigh up when choosing a strength and quantity, alongside the practical medical background and UK access rules that apply. Because an available pack may contain more tablets than one treatment course requires, the prescribed strength and quantity should guide the choice rather than pack size alone.
Every order starts with three linked decisions: strength, quantity, and how that quantity fits the course a prescriber has set out. We list Cipro as an oral, film-coated tablet in 250 mg, 500 mg and 750 mg strengths, mirroring the strengths used in UK clinical practice for ciprofloxacin. Pack sizes differ by strength: 250 mg tablets come in packs of 90, 120, 180 and 360; 500 mg tablets in packs of 60, 90, 120, 180, 270 and 360; and 750 mg tablets in packs of 30, 60, 90, 120, 180 and 360. Because Cipro is the established brand name for ciprofloxacin, the active ingredient, dosage form and route are the same as those of standard oral ciprofloxacin tablets described in UK reference sources; what differs between our listed options is strength and pack size, not the active medicine.
For Cipro 500 mg, we offer our widest range of pack sizes: 60, 90, 120, 180, 270 and 360 tablets. Comparing the total price with the unit price for each option shows where the relative savings lie, but the lowest price per tablet does not make a larger pack clinically appropriate when fewer tablets have been prescribed.
Use the comparison image above to weigh the exact price, unit value and savings for each 500 mg pack size we currently list. A larger pack may lower the price per tablet, but it only represents practical value when the full quantity forms part of an established treatment plan and is expected to be used before the expiry date printed on the pack. Buying tablets for a possible future course does not improve treatment and can leave medicine unused or encourage inappropriate antibiotic use.
Choosing between 250 mg, 500 mg and 750 mg is a clinical decision that depends on the infection being treated, its severity, kidney function and other factors a prescriber weighs up. Once that strength is confirmed, the quantity decision becomes practical: how many tablets does the prescribed course actually require, and does an available pack correspond to that quantity? The table below sets out the pack sizes we hold for each strength, so availability can be checked against a prescribed course before ordering.
| Strength | Pack sizes available (tablets) |
|---|---|
| 250 mg | 90, 120, 180, 360 |
| 500 mg | 60, 90, 120, 180, 270, 360 |
| 750 mg | 30, 60, 90, 120, 180, 360 |
A few practical points help translate that table into the right choice:
Cipro is the long-established brand name under which ciprofloxacin has been supplied, and the tablets we list share the same active ingredient, dosage form and route as standard oral ciprofloxacin described in UK prescribing information. Ciprofloxacin belongs to the fluoroquinolone class of antibiotics, which also includes agents such as levofloxacin, ofloxacin and moxifloxacin; these share a broadly similar mechanism but differ in spectrum, dosing and side-effect profile, so one cannot simply be substituted for another without clinical advice.
Where a different spectrum or a narrower-acting option suits an infection better, we also stock Moxifloxacin, another fluoroquinolone with a distinct pattern of use, alongside Nitrofurantoin and Fosfomycin, which are commonly used for uncomplicated lower urinary tract infections when the organism, patient and clinical circumstances make them appropriate. Customers comparing options across our range can also browse our full Antibiotics selection.
Ciprofloxacin is a broad-spectrum antibiotic with particularly strong activity against Gram-negative bacteria, including Pseudomonas aeruginosa, which makes it useful where that coverage matters. UK prescribing information and NHS guidance describe its use across a range of bacterial infections, including:
Whether ciprofloxacin is the right choice for a given infection depends on the organism suspected or confirmed, local resistance patterns and the person's medical history. UK safety guidance restricts systemic fluoroquinolone use to situations in which other commonly recommended antibiotics are inappropriate, so ciprofloxacin is not a general-purpose antibiotic.
Ciprofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes bacteria need to copy and repair their DNA; blocking them is bactericidal, meaning bacteria are killed rather than merely prevented from multiplying. Oral ciprofloxacin is well absorbed, with peak blood levels typically reached within one to two hours. Many regimens use doses approximately 12 hours apart, but the dose, frequency and course length vary by infection and must follow the prescriber's directions. Dosing may need adjustment when kidney function is reduced, including where relevant in older adults, which is another reason the exact regimen is set individually rather than inferred from the pack.
Ciprofloxacin tablets can be taken with or without food, with water, and adequate hydration is generally advised. They should not be taken with dairy products such as milk or yoghurt, or calcium-fortified drinks, on their own because absorption can be reduced; this restriction does not generally apply to calcium that forms part of an ordinary meal. Antacids and supplements containing calcium, magnesium, aluminium, iron or zinc can also reduce absorption and are generally taken about one to two hours before ciprofloxacin or at least four hours afterwards. Symptoms often start to improve within a few days, but the full course should be completed as prescribed rather than stopped early when symptoms ease.
Ciprofloxacin carries a distinct safety profile compared with many other antibiotic classes, and UK regulatory guidance is explicit that systemic fluoroquinolones, including ciprofloxacin, should be used only when other commonly recommended antibiotics are unsuitable because of the risk of disabling and potentially long-lasting or irreversible effects on tendons, muscles, joints and the nervous system. Points worth being aware of include:
Ciprofloxacin interacts with a number of other medicines. Concomitant use with tizanidine is contraindicated because ciprofloxacin can substantially increase tizanidine exposure and cause clinically significant low blood pressure and sedation. Important interactions can also occur with theophylline, oral anticoagulants such as warfarin, medicines that prolong the QT interval and mineral-containing antacids or supplements; some non-steroidal anti-inflammatory drugs may increase the risk of central nervous system effects. A full medical and medication history is therefore part of assessing whether ciprofloxacin is appropriate, and this general information does not replace an individual review by a prescriber or pharmacist.
Ciprofloxacin tablets are classified as a prescription-only medicine in the United Kingdom, and the MHRA's safety guidance reserves fluoroquinolones for situations where more commonly recommended antibiotics would not be suitable. Ciprofloxacin can also be supplied on the NHS when clinically appropriate, with the usual prescription charges and exemptions applying across the UK nations. Because the name and strength shown on a pack do not by themselves confirm which specific marketing authorisation applies, the PL number and marketing-authorisation holder on the pack received are worth checking against current UK product information.
Separate from that medical classification is how we accept an order: our checkout does not require a prescription upload before an order is accepted, so customers who prefer to order Cipro without uploading a prescription through our process can do so. This describes our ordering policy rather than any change to ciprofloxacin's prescription-only status in the UK, and our pharmacist-supported team remains available for questions about a specific order before it is placed.
Once a strength and pack size are chosen, our checkout confirms the exact option selected before the order is placed. We have supported UK customers since 2010, and our support team is reachable 24 hours a day by email, online chat and phone, with a pharmacist available to help with questions about an order. A typical order runs through the following steps:
Because pack sizes differ by strength, double-checking the strength and quantity at checkout against the prescribed treatment plan is the simplest way to avoid ordering the wrong combination.
The best-value Cipro pack is the available option that most closely reflects the prescribed strength and quantity, with price per tablet considered only after those clinical requirements are settled. Before ordering, check the strength, required number of doses, treatment duration and available package quantity rather than assuming that a larger pack offers better practical value. If every listed pack exceeds the quantity required, do not extend the course or save remaining tablets for a future infection without medical advice. Whichever option is selected, storing the tablets correctly, checking the expiry date and arranging safe disposal of medicine that is no longer needed help ensure that the package choice remains practical as well as cost-conscious.
I live in Lisburn, Northern Ireland. Can I check whether Cipro can be delivered to my postcode before I pay?
Yes. Enter your Lisburn delivery address and postcode at checkout before payment; the available delivery options will show whether the product can be sent to your address.
I have started a course of Cipro and have just found out that I am pregnant. What should I do?
Ciprofloxacin should preferably be avoided during pregnancy. Contact the prescriber promptly, ideally before the next dose, so they can assess the infection, the exposure so far, and whether another treatment is more suitable; do not make changes to the course without that advice.
| Active ingredient | Ciprofloxacin |
|---|---|
| Drug class | Fluoroquinolone antibiotic |
| Dosage form | Film-coated tablet |
| Available strengths | 250 mg, 500 mg, 750 mg |
| Route | Oral |
| Storage | Store at 20°C to 25°C, with brief excursions permitted between 15°C and 30°C; keep the tablets in a tightly closed container away from moisture. |
| ATC code | J01MA02 |
This product has 22 ratings, but only 4 written reviews so far. Share your experience and help other customers.
Within the expected delivery period, my order reached me normally.
Everything was packed properly.
I'd order again.
The outer packaging was discreetly labelled, with nothing about the contents advertised.
